Ferret acute lung injury model induced by repeated nebulized lipopolysaccharide administration. Issue 20 (21st October 2022)

• Record Type: Journal Article
• Authors: Khoury, Oula; Clouse, Cara; McSwain, Malcolm K.; Applegate, Jeffrey; Kock, Nancy D.; Atala, Anthony; Murphy, Sean V.
• Is Part Of: Physiological reports. Volume 10:Issue 20(2022)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2022-10-21
• Subjects: acute lung injury -- acute respiratory distress syndrome -- ferret model -- lipopolysaccharide -- lung function testing; Physiology -- Periodicals; 571
• DOI: 10.14814/phy2.15400
• Languages: English
• ISSNs: 2051-817X

Abstract

Abstract: Inflammatory lung diseases affect millions of people worldwide. These diseases are caused by a number of factors such as pneumonia, sepsis, trauma, and inhalation of toxins. Pulmonary function testing (PFT) is a valuable functional methodology for better understanding mechanisms of lung disease, measuring disease progression, clinical diagnosis, and evaluating therapeutic interventions. Animal models of inflammatory lung diseases are needed that accurately recapitulate disease manifestations observed in human patients and provide an accurate prediction of clinical outcomes using clinically relevant pulmonary disease parameters. In this study, we evaluated a ferret lung inflammation model that closely represents multiple clinical manifestations of acute lung inflammation and injury observed in human patients. Lipopolysaccharide (LPS) from Pseudomonas aeruginosa was nebulized into ferrets for 7 repeated daily doses. Repeated exposure to nebulized LPS resulted in a restrictive pulmonary injury characterized using Buxco forced maneuver PFT system custom developed for ferrets. This is the first study to report repeated forced maneuver PFT in ferrets, establishing lung function measurements pre‐ and post‐injury in live animals. Bronchoalveolar lavage and histological analysis confirmed that LPS exposure elicited pulmonary neutrophilic inflammation and structural damage to the alveoli. We believe this ferret model of lung inflammation, with clinically relevant disease manifestations and parameters for functional evaluation, is a useful pre‐clinical model for understanding human inflammatory lung disease and for the evaluation of potential therapies. Abstract : We developed a ferret model of lung inflammation, with clinically relevant disease manifestations and parameters for functional evaluation, which can be a useful pre‐clinical model for understanding human inflammatory lung disease and for evaluation of potential therapies.